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ABSTRACT* 
Objectives: The primary objective was to expand 
upon results of a previously piloted patient 
perception survey with Healthcare Failure Mode and 
Effect Analysis (HFMEA), to identify areas within 
pharmacist-managed clinics needing improvement.  
Methods: The survey was adapted for use in 
pharmacist-managed clinics. Patients completed the 
survey following regularly scheduled pharmacist 
appointments.  Data were analyzed with a method 
adapted from HFMEA.  Product scores could range 
from five to 25. A product of five indicates that 
pharmacists are doing a good job on the items that 
patients place the most value on, while a product 
score of 25 indicates that pharmacists are doing a 
poor job.  A score greater than or equal to ten was 
used to identify areas for improvement.   
Results: Seventy-one patients completed surveys. 
Thirteen components were assessed and no item 
achieved a mean product greater than or equal to 
ten. The survey item with the highest mean product 
pertained to discussion of potential medication side 
effects (mean: 7.06; interquartile range: 5-10). 
Analysis of each survey item found that all survey 
items had multiple individual responses that 
provided a product score of greater than or equal to 
ten. The survey items most frequently listed in the 
overall population as being most valued were “Told 
you the name of each of your medicines and what 
they are used for”, “Answered your questions fully,” 
and “Explained what your medicines do”.  
Conclusions: Educational components provided 
during pharmacist-managed clinic appointments are 
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aligned with patients’ needs and are successfully 
incorporating the components that patients value 
highly in a patient-healthcare provider interaction. 
The HFMEA model can be an important teaching 
tool to identify specific processes in need of 
improvement and to help enhance pharmacists’ 
self-efficacy, which may further improve patient 
care. 
 
Keywords: Pharmaceutical Services; Delivery of 
Health Care; Systems Analysis; Total Quality 
Management; United States 
 
ESTUDIO DE CONSULTAS DE ATENCIÓN 
PRIMARIA GESTIONADAS POR 
FARMACÉUTICOS USANDO EL ANÁLISIS  
DE MODOS Y EFECTOS DE FALLOS EN 
SALUD 
 
RESUMEN 
Objetivos: El objetivo primario fue profundizar 
sobre los resultados de un cuestionario pre-pilotado 
de percepciones de los pacientes con el análisis  de 
modos y efectos de fallos en salud (HFMEA) para 
identificar áreas en las que las consultas de 
farmacéuticas necesitan mejorar. 
Métodos: El cuestionario fue adaptado para su uso 
en consultas farmacéuticas. Los pacientes cubrieron 
el cuestionario después de las citas farmacéuticas 
acordadas. Los datos se analizaron usando un 
método adaptado del HFMEA. Las puntuaciones de 
producto podían oscilar de 5 a 25. Un producto de 5 
indicaba que el farmacéutico estaba realizando un 
buen trabajo en los ítems que el paciente valorizaba 
más, mientras que una puntuación de 25 indicaba 
que el farmacéutico estaba haciendo un mal trabajo. 
Se utilizaron las puntuaciones de 10 o más para 
identificar áreas de mejoría. 
Resultados: 71 pacientes completaron 
cuestionarios. Se evaluaron 33 componentes y 
ningún ítem alcanzó un producto medio mayor o 
igual a 10. El punto de la encuesta que alcanzó la 
media más alta trataba de la discusión de los 
potenciales efectos secundarios de la medicación 
(media: 7.06; rango intercuartilico: 5-10). El 
análisis de cada ítem del cuestionario encontró que 
todos los ítems tenían varias respuestas individuales 
que proporcionaban una puntuación igual o mayor 
de 10. Los ítems más frecuentemente considerados 
por la población total como siendo los más 
valorados fueron “le dijo el nombre de todos sus 
medicamentos y para que se usan”, “respondió 
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completamente sus preguntas” y “explico lo que 
hacen los medicamentos”. 
Conclusiones: Los componentes educativos 
proporcionados en las visitas a las consultas 
farmacéuticas se alinean con las necesidades de los 
pacientes e incorporan con éxito los componentes 
que los pacientes valoran más en la interacción 
paciente-profesional de la salud. El modelo 
HFMEA puede ser una importante herramienta 
educativa para identificar procesos específicos que 
necesitan mejorar y para ayudar a aumentar la auto-
eficacia de los farmacéuticos, lo que podrá en el 
futuro mejorar la atención a pacientes. 
 
Palabras clave: Servicios Farmacéuticos; 
Prestación de Atención de Salud; Análisis de 
Sistemas; Gestión Total de la Calidad; Estados 
Unidos 
 
 
INTRODUCTION 
The recognition of pharmacists as healthcare 
providers in recent Medicare legislation is an 
important step in the expansion and acceptance of 
clinical pharmacy services.1 It has been widely 
accepted within pharmacy organizations that 
pharmaceutical care should be the focus of all 
pharmacists.2 This emphasis on pharmaceutical 
care and pharmacist-patient interaction is also 
widely noted within regulations enacted by 
Congress.3,4 There are many documented benefits 
of pharmacist-managed care on disease outcomes5-
9, but information related to patient perceptions of 
pharmacist-managed care is lacking. As previously 
demonstrated by Gonzalvo and colleagues, there 
are consistent and emerging themes related to 
patient perceptions of pharmacist-managed care10, 
but there is limited guidance to help identify whether 
process improvement is needed in the clinical 
pharmacist-patient interaction. To compensate for 
the sparse amount of qualitative data relating to 
pharmacist-managed care, survey data have 
routinely been collected to determine patient 
satisfaction and perceptions of care.11,12  
Recognizing the subjectivity of survey results, 
Healthcare Failure Mode and Effect Analysis 
(HFMEA) is a method that has been successfully 
implemented to add weight to the importance of 
survey responses by assigning numerical value.13 
Traditionally, HFMEA has been used to proactively 
evaluate healthcare processes and identify areas 
for improvement or to enhance an existing service. 
Healthcare Failure Mode and Effect Analysis has 
also been used to identify a cause and effect 
relationship to reduce medication errors.14,15 
HFMEA can provide a useful measure to improve 
clinical pharmacy services by identifying areas with 
the greatest impact based on what the patient 
values as important. 
As opportunities for pharmacists continue to grow, 
those services offered must be evaluated to 
determine if they are consistent with what is valued 
by patients.  The research noted by Knight and 
Caudill focused on a pharmacotherapy clinic at one 
Veterans Affairs  Medical Center.13 This study builds 
upon their previous work by using the HFMEA 
model based on surveys of patients referred to the 
clinical pharmacist for disease state management 
across multiple pharmacist-managed clinics.  
The primary objective of this multicenter study was 
to expand upon the results of a previously piloted 
patient perception survey with HFMEA13, to identify 
areas within pharmacist-managed clinics that need 
improvement based on patient perceptions. 
 
METHODS  
This study was conducted at six pharmacist-
managed clinics within the central Indiana region, 
with data collection occurring over a six-week period 
between January and June 2012. Pharmacist-
managed clinics were included based upon 
similarities in clinic location (i.e.; urban setting) and 
scope of clinical pharmacy services offered (i.e.; 
collaborative practice agreements for chronic 
disease management). Four of the six clinic sites 
generate patient charges for pharmacist 
appointments per their institution specific guidelines. 
Approval was obtained from each site’s Institutional 
Review Board (IRB), and to maintain patient 
anonymity, no patient identifiers were recorded. 
Survey Development 
The survey utilized in this study was adapted with 
permission from a previously published patient 
perception survey and was adjusted for utilization in 
participating pharmacist-managed clinics. The 
survey was originally designed to measure patient 
perceptions of the quality of education provided at a 
single Veteran’s Affairs institution.13 For the current 
study, the survey was expanded to incorporate a 
variety of pharmacist-managed clinics at multiple 
institutions across different health systems, to 
identify common areas of the pharmacist-patient 
interaction in need of improvement. Patients were 
instructed to respond based on only the medications 
and disease states managed by the pharmacist, not 
all medications and disease states.  
Survey Implementation 
The 27-item survey (online supplementary material) 
was distributed to six participating pharmacists for 
use in their pharmacist-managed clinic. Patients are 
referred to these pharmacist-managed clinics by 
their physicians for education and medication 
management. Each clinical pharmacist works 
closely with their patients and providers through a 
collaborative practice agreement to adjust 
therapies, obtain and assess necessary monitoring 
parameters, and help achieve desired therapeutic 
outcomes.  The disease states managed were 
specific to each pharmacist-managed clinic and 
included anticoagulation, diabetes, hyperlipidemia, 
hypertension, smoking cessation, and general 
pharmacotherapy clinics.  Patients presenting for 
routine follow-up in a participating pharmacist-
managed clinic were eligible for inclusion, while 
patients under 18 years of age, had less than two 
prior visits with the pharmacist, or who were unable 
to read English were excluded from the study. 
Vincent AH, Gonzalvo JD, Ramsey DC, Walton AM, Weber ZA, Wilhoite JE. Survey of pharmacist-managed primary 
care clinics using healthcare failure mode and effect analysis. Pharmacy Practice 2013 Oct-Dec;11(4):196-202. 
www.pharmacypractice.org      (ISSN: 1886-3655) 198
Eligible patients were recruited to participate 
immediately following a regularly scheduled 
appointment with the clinical pharmacist and were 
asked to complete the survey in the waiting room or 
empty exam room. Each patient was provided with 
written instructions, and completed surveys were 
given to reception staff within each clinic. The 
surveys were administered over a six week period 
to capture as many eligible patients as possible; 
however, each institution utilized a different six 
week period within the data collection period based 
on participating pharmacists’ availability. Each 
eligible patient completed one survey during the six 
week study period, regardless of number of visits 
with the pharmacist during that time. There was no 
randomization or patient selection criteria other than 
the exclusion criteria previously defined. 
Statistical Analysis 
Data were analyzed with a method adapted from 
that used in a HFMEA process and with standard 
descriptive statistical methods, to examine quality 
improvement results. The HFMEA is a prospective 
assessment that provides a method for placing 
weights on outcomes (i.e.: assigning a value to the 
importance of various components of patient 
education based on what the patient feels is most 
important). This allows for results to be prioritized 
and easy identification of areas for improvement 
based on numerical scores. For this analysis, 
product scores could range from a score of five to 
25, with a product value of five indicating that 
pharmacists are doing a good job on the items that 
patients place the most value on while a product 
score of 25 would indicate that pharmacists are 
doing a poor job on the items that patients feel are 
most important. The specific steps used for 
calculating the HFMEA scores have been published 
previously13, and include scoring each survey 
component to be assessed, then multiplying 
corresponding components from sections 1 and 2 of 
the survey to determine an overall product score for 
that item.  Traditionally, a product greater than one-
half of the highest score is used to indicate the need 
for improvement when using a HFMEA method. To 
maintain consistency with previously published 
methods, a conservative final score greater than or 
equal to 10 was used to identify areas for 
improvement across the pharmacist-managed clinic 
sites.   
 
RESULTS  
A total of 71 patients completed surveys during the 
data collection period. Fifty percent of survey 
respondents were male, with an average age of 
56±12 years (Table 1).  Of the 13 components 
assessed, no item achieved a mean product of 
greater than or equal to ten (Table 2). Survey item 
4, “Described the possible side effects of each of 
your medicines,” had the highest overall mean 
product at 7.05. Analysis of each survey item found 
that all survey items had multiple individual 
responses that provided a product score of greater 
than or equal to ten (Figure 1). When evaluating the 
survey responses based on the specific disease 
state managed by the pharmacist, the patients with 
diabetes had the highest mean product for survey 
item 4 with a product score of 7.5. This score was 
lowest at 6.3 for patients seeing the clinical 
pharmacist for management of warfarin therapy. 
Survey item 5, “Provided information about your 
medical problems and the benefits of treating them”, 
had the second highest overall mean product score 
Table 1. Patient Demographics 
Average age in years (SD)  56 (12) 
Gender* 
Male  
Female 
 
36 (50.7%) 
35 (49.3%) 
Ethnicity*  
        Hispanic or Latino 
        Not Hispanic or Latino  
 
1 (1.4%) 
70 (98.6%) 
Race** 
        American Indian/Alaska Native 
        Asian 
        Black/African American 
        Native Hawaiian/Pacific Islander 
        White/Caucasian 
 
3 (4%) 
1 (1.4%) 
26 (37.1%) 
0 
40 (57.1%) 
No. of past pharmacist-managed clinic 
visits*  
        2 
        3-4 
        5-7 
        8-10 
        >10 
 
14 (34.1%) 
21 (29.6%) 
11 (15.5%) 
13 (18.3%) 
12 (16.9%) 
Prescription Drug coverage*** 
        Institution specific 
        Medicaid/Medicare 
        Private 
        Cash/no third party  
 
32 (47.8%) 
21 (31.3%) 
6 (9.0%) 
7 (10.4%) 
Total average no. of medications per 
patient (SD)+ 8.1 (5.3) 
Average no. of medications managed by 
pharmacist per patient (SD)+ 4.2 (3.6) 
Pharmacist-managed disease state*  
        Diabetes 
        Warfarin (Coumadin) management 
        High blood pressure 
        Quitting smoking 
        High cholesterol 
        Other 
 
34 (47.9%) 
19 (26.7%) 
30 (42.2%) 
3 (4.2%) 
42 (59.2%) 
3 (4.2%)**** 
Duration of pharmacist-managed 
disease state in years (SD) ++  6.5 (7.4) 
* n=71 ** n=70 *** n=67 + n=69 ++ n=65 
**** Total is greater than 100% due to patients having 
multiple pharmacist-managed disease states 
Figure 1. Number of Individual responses with product 
score ≥10 (n=71) *n=70; **n=68 
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at 6.31. The mean product score was highest 
among patients seeing the pharmacist for 
hyperlipidemia management (mean=6.5) and lowest 
among patients seeing the pharmacist for warfarin 
management (mean=5.9). The majority of the 
remaining overall mean products were in the 5 to 6 
point range.  
The final non-demographic survey question asked 
patients to list three items they most valued. Of the 
53 patients that responded, those items listed most 
often were “Told you the name of each of your 
medicines and what they are used for”, “Answered 
your questions fully”, and “Explained what your 
medicines do”. The specific frequencies of response 
by survey item can be found in Table 3. The six 
items most frequently listed as being “most valued” 
by patients all had a mean product <5.9. The 
frequency of the most valued educational 
components was compared between 
Males/Females (Figure 2) and African 
Americans/Caucasians (Figure 3). Males rated 
survey items 8 and 11  as most valued more often 
than females; females rated survey items 6, 7 and 
10 as most valued more often than males. African 
American participants rated survey items 4, 7, 10, 
and 12 more often than Caucasian participants; 
Caucasian participants more frequently rated survey 
items 1, 3, and 6 compared with African American 
participants. 
 
DISCUSSION 
The results obtained from this survey indicate that, 
collectively, clinical pharmacists are performing at a 
satisfactory level during each pharmacist-patient 
visit. No item achieved a product score high enough 
to be flagged as needing improvement based on 
HFMEA methods. Assessing the individual product 
scores has highlighted areas on which to focus 
future quality improvement efforts (i.e.: describing 
the possible side effects of each of medicine). 
Interestingly, these results, along with prior 
results13, found that the individual response most 
commonly associated with a score of greater than 
or equal to ten related to the discussion of potential 
medication side effects. This may indicate that 
pharmacists working in a pharmacist-managed 
clinic feel it is more important to focus on overall 
disease state management and perhaps assume 
that the pharmacist dispensing the prescription will 
educate the patient on the medication itself, 
including the possible side effects. Additionally, side 
effects may have been discussed when medication 
was initiated, but not emphasized at each patient 
visit if no medication changes were being made. 
Pharmacists working in pharmacist-managed clinics 
should develop ways to incorporate this educational 
component into patient interactions.  
When looking at the items frequently marked as 
being the most valued by patients overall, the 
product scores indicate that clinical pharmacists are 
satisfying patients’ expectations across a variety of 
pharmacist-managed clinic settings. However, when 
looking at specific patient populations there are 
some differences in what is valued most highly 
during an appointment with a clinical pharmacist. 
Male participants more strongly valued 
communication in a way that could be easily 
understood and that fully answered questions than 
the female participants. The female participants 
Table 3: Survey Responses Listed as 1 of 3 Most Valued Items 
Survey Item No. of Responses  n = 53 
Told you the name of each of your medicines and what they are used for 26 
Answered your questions fully 24 
Explained what your medicines do 18 
Treated you with respect and courtesy 17 
Instructed you on how you should take your medicines 15 
Talked to you in a way you could easily understand 14 
Described the possible side effects of each of your medicines 11 
Discussed goals of treatment for each of your medical problems 11 
Provided information about your medical problems and the benefits of treating them 7 
Talked to you about the next steps in managing your medical problems 7 
Spent plenty of time with you 6 
Discussed the resources available to help you with your medications 2 
Rating of your clinical pharmacy visits overall 1 
Table 2. Survey Results 
Survey Item Mean Product (IQ range) n=71 
1. Told you the name of each of your medicines and what they are used for 5.79 (5-5)* 
2. Explained what your medicines do 5.85 (5-5)* 
3. Instructed you on how you should take your medicines 5.83 (5-10) 
4. Described the possible side effects of each of your medicines 7.06 (5-10) 
5. Provided information about your medical problems and the benefits of treating them 6.31 (5-8) 
6. Discussed goals of treatment for each of your medical problems 6.01 (5-7) 
7. Talked to you about the next steps in managing your medical problems 6.07 (5-7) 
8. Answered your questions fully 5.63 (5-5) 
9.  Discussed the resources available to help you with your medications 6.35 (5-7) 
10.  Spent plenty of time with you 5.69 (5-5)** 
11.  Talked to you in a way you could easily understand 5.41 (5-5) 
12. Treated you with respect and courtesy 5.54 (5-5) 
13.  Rating of your clinical pharmacy visits overall 6.01 (5-5) 
* n=70; **n=68 
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Figure 3: Survey Responses Listed as 1 of 3 Most Valued Items (African American=18 / Caucasian=32) 
placed a higher value on discussing goals of 
treatment and next steps of therapy, along with 
spending plenty of time with the patient, than did the 
male participants. Additionally, African American 
participants more frequently ranked being treated 
with respect and courtesy as a highly valued 
appointment component than did Caucasian 
participants, while Caucasian participants more 
frequently ranked being told how to take their 
medications. These differences among patient 
populations illustrate the need for continued 
awareness on the part of the clinician in a 
pharmacist-managed clinic to ensure that each 
patient is getting the most out of their individual 
appointment by including components that are most 
likely to be highly valued.    
The results found in this study are consistent with 
the previously published qualitative data on 
pharmacist-patient interactions10,13 and support the 
idea that disease state management by pharmacists 
is a successful extension of care for chronic 
diseases. Time constraints in primary care often 
limit the services that can be provided by 
Figure 2. Survey responses listed as 1 of 3 most valued items (Males=27 / Females=26) 
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physicians.16,17 Not only are pharmacists able to 
spend increased time with patients, but they are 
also able to do it in a way that often exceeds patient 
expectations of a patient-healthcare provider 
interaction.  
The use of HFMEA as a clinical process 
improvement tool is a novel concept that can be 
applied to all aspects of pharmaceutical care, not 
just pharmacist-managed clinics. It is an important 
tool that can help pharmacists to identify areas of 
success as well as areas in need of improvement. 
An additional benefit to using the HFMEA model is 
its application as an important teaching tool to help 
increase pharmacists’ self-efficacy, which may 
further improve patient care. 
While the survey used in this research was 
originally designed to measure patient perceptions 
of the quality of pharmacist education provided at a 
single Veteran’s Affairs institution affiliated clinics 
and found positive results in a small number of 
patients13, the current study expanded the survey 
distribution to incorporate a variety of pharmacist-
managed clinics at multiple institutions across 
different health systems, both Veteran’s Affairs and 
non-Veteran’s Affairs. The low number of overall 
participants in these studies highlights a larger 
challenge presented to pharmacist-managed clinics, 
the number of patients that do not keep their 
scheduled appointments. The survey was offered to 
each patient presenting to a pharmacist-managed 
clinic appointment during a six week period, unless 
they had already completed the survey. Patients 
were allowed to decline participation, but the 
majority of presenting patients chose to participate. 
The overall number of scheduled appointments 
during the six week survey period was significantly 
higher than 71. Many of the participating 
pharmacist-managed clinics had a patient no-show 
rate of greater than 50 percent, leading to a smaller 
than expected response rate.  
The use of patient surveys as a research method is 
subjective by nature and open to bias. Steps were 
taken to minimize this bias by collecting data 
anonymously, allowing patients to skip questions 
they were not comfortable answering, and turning in 
completed surveys to non-pharmacy clinic staff.  
The study was not designed in a way to compare 
results between patients receiving pharmacist-
managed care, and those not receiving pharmacist-
managed care. As a result, no statements regarding 
the statistical significance of the data can be made; 
however, this does not limit the clinical significance 
or practical application of applying HFMEA results 
to identify areas that need improvement during a 
pharmacist-managed clinic appointment. 
HFMEA scales are completely subjective in nature 
and item values are determined by those 
developing the scale. The authors attempted to limit 
subjectivity by using the same scale and analysis 
method that has been previously published. 
Additionally, HFMEA is intended to be used as a 
tool for process improvement. Each pharmacist’s 
process may not be identical, introducing variables 
into the analysis. However, the items assessed by 
this survey are a part of each pharmacist-patient 
encounter and are similar across a variety of 
pharmacist-managed clinic settings. Based on the 
largely positive results obtained in this study, as well 
as the prior study by Knight and Caudill13, it should 
be considered whether or not the HFMEA tool is 
sensitive enough to identify areas in need of 
improvement in highly functioning pharmacist-
managed clinics. Further research involving both 
newly developed and well established pharmacist-
managed clinics should be conducted to test the 
sensitivity and validity of this HFMEA tool. 
 
CONCLUSIONS 
These results, combined with the results published 
by Knight and Caudill13, indicate that educational 
components provided during pharmacist-managed 
clinic appointments are aligned with patients’ needs 
and clinic based pharmacists are able to 
successfully incorporate the components that 
patients value highly in a patient-healthcare provider 
interaction. The HFMEA model can be utilized as an 
important teaching tool to identify specific processes 
in need of improvement and to help enhance 
pharmacists’ self-efficacy, which may further 
improve patient care.  
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